Since then, its aberrations, such as rearrangements and gene copy number gains, have been found in many other malignant and benign neoplasms, e.g., EML4-ALK translocations occurring in 2–7% of lung adenocarcinomas [12]. This evidence concerns the gene ALK and lung adenocarcinoma.